Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 38, 2014 - Issue 3
120
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of the National Prevention Program in Iran, 2007–2009: the Accomplishments and Challenges with Reflections on the Path Ahead

, , , , &
Pages 179-187 | Received 31 May 2013, Accepted 08 Nov 2013, Published online: 26 Mar 2014

References

  • Alwan A, Modell B. Recommendation for introducing genetics services into developing countries. Nat Rev Genet. 2003;4(1):61–68
  • Rahim F, Saki N, Jalalifar MA. The role of genetic mutation detection in defining the spectrum of β-thalassaemia in various ethnic regions. In: Plaseska-Karanfilska D, Ed. Human Genetic Diseases. Rijeka: InTech. 2011:109–120. (Available at http://www.intechopen.com/books/human-genetic-diseases/the-role-of-gene-mutations-detection-in-defining-the-spectrum-of-thalassemia-in-various-ethnic-regio.) ISBN 978-953-936-3
  • Bozkurt G. Results from the North Cyprus thalassemia prevention program. Hemoglobin. 2007;31(2):257–264
  • Loukopoulos D. Haemoglobinopathies in Greece: Prevention programme over the past 35 years. Indian J Med Res. 2011;134(4):572–576. Review
  • Samavat A, Modell B. Iranian National Thalassaemia Screening Programme. BMJ. 2004;329(7475):1134–1137
  • Alwan AA, Modell B. Community control of genetic and congenital disorders. (EMRO Technical Publications Series 24). Alexandria: World Health Organization Regional Office for the Eastern Mediterranean; 1997. (Available at http://www.who.int/dsa/cat98/gene8.htm.) ISBN 92-9021-220-9
  • Abolghasemi H, Amid A, Zeinali S, et al. Thalassemia in Iran: Epidemiology, prevention, and management. J Pediatr Hematol Oncol. 2007;29(4):233–238
  • Strauss BS. Genetic counseling for thalassemia in the Islamic Republic of Iran. Perspect Biol Med. 2009;52(3):364–376
  • Najmabadi H, Ghamari A, Sahebjam F, et al. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet. 2006;9(2):93–97
  • Keslin A, Turk T, Polat A, et al. Premarital screening of β-thalassemia trait in the Province of Denizli, Turkey. Acta Hematol. 2000;104(1):31–33
  • Abi Saad M, Aoun S, Maatouk P. The thalassemia prevention program at the Chronic Care Center in Lebanon: A success story. Proceedings of the 12th International Conference on Thalassemia and other Haemoglobinopathies, Ankara, Turkey, May 11–14, 2001
  • Memish ZA, Saeedi MY. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia. Ann Saudi Med. 2011;31(3):229–235
  • Madan N, Sharma S, Sood SK, et al. Frequency of β-thalassaemia trait and other haemoglobinopathies in northern and western India. Indian J Hum Genet. 2010;16(1):16–25
  • Khorasani G, Kosaryan M, Vahidshahi K, et al. Results of the national program for prevention of β-thalassemia major in the Iranian Province of Mazandaran. Hemoglobin. 2008;32(3):263–271
  • Nikuei P, Hadavi V, Rajaei M, et al. Prenatal diagnosis for β-thalassemia major in the Iranian Province of Hormozgan. Hemoglobin. 2008;32(6):539–545
  • Ghanei M, Abidi P, Movahedi M, et al. Premarriage prevention of thalassemia: Report of a 1 00 000 case experience in Isfahan. Public Health. 1997;111(3):153–156
  • Hadipour Dehshal M, Ahmadvand A, Darestani SY, et al. Secular trends in the national and provincial births of new thalassemia cases in Iran from 2001 to 2006. Hemoglobin. 2013;37(2):124–137
  • Eshghi P, Cheraghali AM. Legal, social, and economic consequences of transfusion transmitted infections in Iran and in the world. Sci J Iranian Blood Transfus Organ. 2009;6(4):301–311
  • Report of a World Health Organization Meeting on Ethical Issues in Medical Genetics. Proposed international guideline on ethical issues in medical genetics and genetics services. (http://www.who.int/genomics/publications/en/ethical guidelines 1998. Accessed February 2013)
  • Kosarian M, Vahidshahi K, Siami R, et al. Knowledge, attitude, and practice of reproductive behavior in Iran minor thalassemia couples. Saudi Med J. 2009;30(6):835–839
  • Ghotbi N, Tsukatani T. Evaluation of the national health policy of thalassaemia screening in the Islamic Republic of Iran. East Mediterr Health J. 2005;11(3):308–318
  • Miri-Moghaddam E, Naderi M, Izadi S, Mashhadi M. Causes of new cases of major thalassemia in Sistan and Baluchestan province in South-East of Iran. Iran J Public Health. 2012;41(11):67–71
  • Abbasi-Shavazi MJ, McDonald M, Chavoshi MH. Changes in family, fertility behavior and attitudes in Iran; working paper in Demography and Sociology Program; Research School of Social Sciences; The Australian National University; No. 88; 2003 (accessed February 2014). (https://digitalcollections.anu.edu.au/bitstream/1885/41501/4/88.pdf.)
  • Parvin P. Poverty alleviation in Sistan & Baluchestan: The case of Shirabad; Allameh Tabatabaii University, Tehran, Iran. Tehran: United Nations Development Program in the Islamic Republic of Iran; 2000
  • Kuliev A, Pakhalchuk T, Verlinsky O, Rechitsky S. Preimplantation genetic diagnosis for hemoglobinopathies. Hemoglobin. 2011;35(5–6):547–555
  • Walsh AP, Omar AB, Marron KD, et al. Recipient screening in IVF: First data from women undergoing anonymous oocyte donation in Dublin. Reprod Health. 2011;8:8. (Available at http://www.thealthwell.info/node/84198. Accessed February 1 2014)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.